Last week, Vivek Ramaswamy's biggest bet, on the Alzheimer's drug being developed by Axovant Sciences, failed. This morning, one of his smaller ones came through: a treatment for uterine fibroids being tested by Myovant, another company started by Ramaswamy's vehicle, Roivant.
from Forbes Real Time https://www.forbes.com/sites/matthewherper/2017/10/03/roivant-wins-a-battle/
via IFTTT
No comments:
Post a Comment